General Hospital Of Athens Korgialenio Benakio H.R.C.

Athens 11 trials 6 recruiting

11 Registered trials

6 Currently recruiting

Organisation

General Hospital Of Athens Korgialenio Benakio H.R.C.

Location

Athens, Greece

Identifier

ORG-100042984

Address

Athanasaki 2 Str, 115 26, Greece

Departments

1st Cardiology Clinic
1st Department of Internal Medicine
2nd Department of Cardiology
3rd Department of Internal Medicine
Cardiology Dpt
Department of Endocrinology and Metabolism - Diabetes Center
Department of Neurology
Infectious Diseases Unit
Intensive Care Unit
Nephrology Department

Clinical trials at this site (11)

Search interface

Combined Dose-Finding and CV Outcomes Study with CSL300 (Clazakizumab) in Adult Subjects with ESKD Undergoing Dialysis (POSIBIL6ESKD). Recruiting

2022-500273-14-00 Atherosclerotic cardiovascular disease in patients with 10 2023-07-17
ZENITH: Zilebesiran in Patients with Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk … Recruiting

2025-522960-34-00 Established cardiovascular disease 5 2026-02-09
A Double-Blind, Placebo-Controlled, Crossover Pilot Study of the Efficacy and Safety of Fluasterone Buccal Tablet in the Control of Hypergly… Recruiting

2023-508322-10-00 Cushing Syndrome 4 2025-05-02
Phase III study to evaluate the effect of balcinrenone/dapagliflozin in patients with heart failure and impaired kidney function Recruiting

2023-508162-15-00 Chronic HF and comorbid impairment of kidney function w 5 2024-07-12
Biomarker-Guided Early Clarithromycin Treatment To Prevent Sepsis Progression In Community-Acquired Pneumonia: The REACT Randomized Clinical… Recruiting

2023-507295-40-00 Community-acquired pneumonia 5 2024-02-12
EMAPALUMAB TREATMENT FOR ANTICIPATED CLINICAL BENEFIT IN SEPSIS DRIVEN BY THE INTERFERON-GAMMA ENDOTYPE (THE EMBRACE TRIAL) Ended

2024-515255-38-00 SEPSIS 4 2025-03-12
A study to evaluate the efficacy, safety, and tolerability of using an oral once-daily 2 drug regimen compared to an oral once-daily 3 drug … Ended

2023-504993-40-00 Human immunodeficiency virus (HIV) 5 2024-02-14
A RANDOMIZED PROSPECTIVE CLINICAL TRIAL TO ASSESS PROCALCITONIN-GUIDANCE AND MOLECULAR-GUIDED DIAGNOSIS AS MAINSTAY FOR THERAPY OF SEVERE IN… Ended

2022-502962-26-00 Severe infections 5 2023-09-14
rIFN-Gamma 1b in Candidemia Ended

2024-510816-55-00 Candidemia 4 2024-11-08
A study to test asundexian for preventing a stroke caused by a clot in participants after an acute ischemic stroke or after a high-risk tran… Ended

2023-503793-20-00 Prevention of ischemic stroke in patients post acute no 5 2023-01-18
A study to learn how well the study treatment asundexian works and how safe it is compared to apixaban to prevent stroke or systemic embolis… Ended

2023-503794-38-00 Prevention of stroke or systemic embolism in atrial fib 5 2022-11-24